Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Differential Diagnosis of Primary Progressive Multiple Sclerosis

Clinical pharmacology and therapy
2018English

Anti-Cd20 Therapy Depletes Activated Myelin-Specific CD8+ T Cells in Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

Frontiers in Neurology
Neurology
2017English

Role of Regulatory T�cells and CD8+�T Lymphocytes in the Dissemination of Circulating Tumor Cells in Primary Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Dysregulated T Cells in Multiple Sclerosis

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2018English

Functional MR Imaging Correlates of Neuropsychological Impairment in Primary-Progressive Multiple Sclerosis

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2010English

Increased CD8+ T Cell Responses to Apoptotic T Cell-Associated Antigens in Multiple Sclerosis

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2013English

P.052 Late-Onset Adrenoleukodystrophy Mimicking Primary Progressive Multiple Sclerosis

Canadian Journal of Neurological Sciences
MedicineNeurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy